BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 15.4//EN BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD DTSTART;VALUE=DATE:20250101 TZNAME:UTC TZOFFSETFROM:+0000 TZOFFSETTO:+0000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:\n\n\n\n\n\n\n\n\nDate: \;Friday 17th March 2023\nTime:&nbs p\;13:00-14:00 GMT\nSpeakers: \;Christine Fletcher \;(GSK)\, Chris ty Mazzarisi \;(Mersana) \;and Paul Frewer \;(AstraZeneca).&nb sp\;\n\nWho is this event intended for? \;Anyone interested in learnin g about or developing leadership skills in the modern day hybrid working w orld.\nWhat is the benefit of attending? \;This session will cover the successes\, challenges and changes needed by our leaders and managers in order to best support the changing workforce\, whether that be in the offi ce\, remote working or a combination of the two. \;\nRegistration\nReg istration for this webinar is free\, and is now open to Members of PSI and  \;Non-Members. We'd love for you to join us!\nTo register for this ev ent\, please \;click here.\nOverview\n\nThis PSI Lunch &\; Learn se ries focuses on career-related topics through a panel discussion\, hosted by Claire Brittain &\; Chetan Mistry.\n\nUpcoming session: \;In the upcoming event - "Modern Leaders: Remote not Distant" - we will be discus sing the need for a conscious evolution of leadership styles as remote wor king becomes commonplace. \;\n\nWhilst there has been a lot of debate on office-based vs. remote workers\, \; there has been less discussion on what 'good' leadership looks like in the new working world. This panel discussion will explore how leaders in our industry have had to adapt\, a djust and evolve in order to remain effective in their roles. \;\nSpea ker details\n\n\n\n \n \n \n Speaker\n \n \n Biography\n \n \n \n \n \n Christy Mazzarisi\n \n \n Innovative and accomplished Quality System s Professional with a broad background in Pharmaceutical and Laboratory sc iences with over 17 years industry practice. Overall background includes b uilding and leading global teams across functions in the biotech and pharm aceutical space. She is passionate about continuous improvement activities and consistently building quality into each area of our lives by providin g coaching\, mentoring and professional support to team members\, employee s\, and many others across industries who want to develop their leadership skills. Chair of Women in Quality group for the American Society for Qual ity\, where she supports building the female leadership pipeline and build ing the future of success across various industries (automotive\, aerospac e\, manufacturing\, technology\, etc.) Advocate and Gala Committee Member for the Tourette&rsquo\;s Association of America\, Advocate for Make-A-Wis h NJ and Powershift Ambassador for Shark Tank&rsquo\;s Daymond John.\n \n \n \n \n \n Paul Frewer\n \n \n Paul has been a statistic ian in the industry for over 25 years\, working for Eli Lilly\, GSK\, Ipse n and AstraZeneca. His initial experiences were as a statistician on post- marketing studies and since then has slowly moved backwards through the ph ases to his current role in early clinical development.He has worked acros s most therapeutic areas and has specialized solely in oncology for the pa st 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Le ader in the Early Oncology Statistics team. He supports multiple different compounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework a nd presented several times on the topic at conferences over the last few y ears.\n \n \n \n \n \n Chrissie Fletcher\n \n \n Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. S he has worked in the Pharmaceutical Industry for over 30 years and has exp erience of developing and commercialising new medicines in a variety of cl inical disease areas across all phases of clinical development. Chrissie i s actively engaged in statistical societies\, pharmaceutical trade associa tions and initiatives relating to the Pharmaceutical Industry such as driv ing innovation in clinical trials and sharing implementation experiences o f the estimand framework. She is an advocate and champion for diversity\, equity and inclusion where she supports a variety of Women Leadership prog rams.\n \n \n \n\n \; DTEND:20230317T140000Z DTSTAMP:20260418T202747Z DTSTART:20230317T130000Z LOCATION: SEQUENCE:0 SUMMARY:PSI Careers Lunch & Learn: Modern Leaders: Remote not Distant UID:RFCALITEM639121408679341105 X-ALT-DESC;FMTTYPE=text/html:Logo r esized
\n
\n
\n
\n
\n
\n
\n
\n
\nDate:  \;Friday 17th March 2023
\nTime: \;13:00-14 :00 GMT
\nSpeakers: \;Christine Fletcher \;< em>(GSK)\, Christy Mazzarisi \;(Mersana) \;and Paul Frewer \;(AstraZeneca). \;
\n
\nWho is this event intended for? \;Anyone interested in learning abou t or developing leadership skills in the modern day hybrid working world.< br />\nWhat is the benefit of attending? \;This sessi on will cover the successes\, challenges and changes needed by our leaders and managers in order to best support the changing workforce\, whether th at be in the office\, remote working or a combination of the two. \;\n

Registration

\n

Registration for this webinar is free\, an d is now open to Members of PSI and \;Non-Members. We'd love for you to join us!
\nTo register for this event\, please \;click here.< /p>\n

Overview

\n

ClaireChet
\n This PSI Lunch &\; Learn series focuses on career-related t opics through a panel discussion\, hosted by Claire Brittain &\; Chetan Mistry.
\n
\nUpcoming session: \;In the upcoming eve nt - "Modern Leaders: Remote not Distant" - we will be discussing the need for a conscious evolution of leadership styles as remote working becomes commonplace. \;
\n
\nWhilst there has been a lot of debate o n office-based vs. remote workers\, \; there has been less discussion on what 'good' leadership looks like in the new working world. This panel discussion will explore how leaders in our industry have had to adapt\, ad just and evolve in order to remain effective in their roles. \;

\n< h4>Speaker details\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
\n

Speaker

\n 		\n

Biography

\n
\n

Christyedit
\n Christy Mazzarisi

\n \n 		\n

Innovative and accomplished Quality Systems Professional with a broad back ground in Pharmaceutical and Laboratory sciences with over 17 years indust ry practice. Overall background includes building and leading global teams across functions in the biotech and pharmaceutical space. She is passiona te about continuous improvement activities and consistently building quali ty into each area of our lives by providing coaching\, mentoring and profe ssional support to team members\, employees\, and many others across indus tries who want to develop their leadership skills. Chair of Women in Quali ty group for the American Society for Quality\, where she supports buildin g the female leadership pipeline and building the future of success across various industries (automotive\, aerospace\, manufacturing\, technology\, etc.) Advocate and Gala Committee Member for the Tourette&rsquo\;s Associ ation of America\, Advocate for Make-A-Wish NJ and Powershift Ambassador f or Shark Tank&rsquo\;s Daymond John.

\n
\n

Pauledit
\n Paul Frewer

\n 		\n

Paul has been a statistician i n the industry for over 25 years\, working for Eli Lilly\, GSK\, Ipsen and AstraZeneca. His initial experiences were as a statistician on post-marke ting studies and since then has slowly moved backwards through the phases to his current role in early clinical development.He has worked across mos t therapeutic areas and has specialized solely in oncology for the past 15 years. He joined AstraZeneca in 2012 and is now a Biometrics Team Leader in the Early Oncology Statistics team. He supports multiple different comp ounds in the oncology therapeutic area across many studies from Phase I up to Phase IIb. He has published on the AZ decision making framework and pr esented several times on the topic at conferences over the last few years.

\n
\n

Chr issieedit
\n Chrissie Fletche r

\n 		\n

Chrissie is the Vice President of Speciality and Primary Care Statistics at GSK. She has worked in the Pharmaceutical Indu stry for over 30 years and has experience of developing and commercialisin g new medicines in a variety of clinical disease areas across all phases o f clinical development. Chrissie is actively engaged in statistical societ ies\, pharmaceutical trade associations and initiatives relating to the Ph armaceutical Industry such as driving innovation in clinical trials and sh aring implementation experiences of the estimand framework. She is an advo cate and champion for diversity\, equity and inclusion where she supports a variety of Women Leadership programs.

\n
\n

 \;

END:VEVENT END:VCALENDAR